Literature DB >> 11058569

Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.

R Umeshita-Suyama1, R Sugimoto, M Akaiwa, K Arima, B Yu, M Wada, M Kuwano, K Nakajima, N Hamasaki, K Izuhara.   

Abstract

IL-4 and IL-13 are pleiotropic cytokines whose biological activities overlap with each other. IL-13 receptor alpha chain 1 (IL-13R alpha 1) is necessary for binding to IL-13, and the heterodimer composed of IL-13R alpha 1 and IL-4R alpha chain transduces IL-13 and IL-4 signals; however, the functional mapping of the intracellular domain of IL-13R alpha 1 is not fully understood. In this study, we constructed wild and mutated types of human IL-13R alpha 1, and analyzed IL-4 and IL-13 signals using an IL-13R alpha 1-transfected human B cell line. Expression of IL-13R alpha 1 evoked STAT3 activation by IL-4 and IL-13, and in stimulated human B cells, on which IL-13R alpha 1 was highly expressed, IL-4 and IL-13 induced STAT3 activation. Replacement of the two tyrosine residues completely abolished STAT3 activation, although replacing either tyrosine residue alone retained it. Furthermore, we found that the Box1 region and the C-terminal tail of IL-13R alpha 1 were critical for binding to Tyk2, and activation of Jak1, Tyk2, the insulin receptor substrate-1 and STAT6 respectively. These results suggest that STAT3 activation is involved with IL-4 and IL-13 signals in human B cells along with the activation of STAT6, and that there is a unique sequence in IL-13R alpha 1 to activate STAT3.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058569     DOI: 10.1093/intimm/12.11.1499

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  19 in total

1.  Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.

Authors:  Stephan Wilmes; Polly-Anne Jeffrey; Jonathan Martinez-Fabregas; Maximillian Hafer; Paul K Fyfe; Elizabeth Pohler; Silvia Gaggero; Martín López-García; Grant Lythe; Charles Taylor; Thomas Guerrier; David Launay; Suman Mitra; Jacob Piehler; Carmen Molina-París; Ignacio Moraga
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

2.  IL-27 and type 2 immunity in asthmatic patients: association with severity, CXCL9, and signal transducer and activator of transcription signaling.

Authors:  Min Xie; Anthony T Mustovich; Yi Jiang; John B Trudeau; Anuradha Ray; Prabir Ray; Haizhen Hu; Fernando Holguin; Bruce Freeman; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2014-10-11       Impact factor: 10.793

3.  IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation.

Authors:  Sara L Hall; Theresa Baker; Stephane Lajoie; Phoebe K Richgels; Yanfen Yang; Jaclyn W McAlees; Adelaide van Lier; Marsha Wills-Karp; Umasundari Sivaprasad; Thomas H Acciani; Timothy D LeCras; Jocelyn Biagini Myers; Melinda Butsch Kovacic; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2016-06-11       Impact factor: 10.793

4.  Genetic reprogramming of tumor cells by zinc finger transcription factors.

Authors:  Pilar Blancafort; Emily I Chen; Beatriz Gonzalez; Sharon Bergquist; Andries Zijlstra; Daniel Guthy; Arndt Brachat; Ruud H Brakenhoff; James P Quigley; Dirk Erdmann; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

Review 5.  Regulation of inflammation by interleukin-4: a review of "alternatives".

Authors:  Irina G Luzina; Achsah D Keegan; Nicola M Heller; Graham A W Rook; Terez Shea-Donohue; Sergei P Atamas
Journal:  J Leukoc Biol       Date:  2012-07-10       Impact factor: 4.962

6.  Interleukin-13 affects the epithelial sodium channel in the intestine by coordinated modulation of STAT6 and p38 MAPK activity.

Authors:  Petra Dames; Theresa Bergann; Anja Fromm; Roland Bücker; Christian Barmeyer; Susanne M Krug; Michael Fromm; Jörg-Dieter Schulzke
Journal:  J Physiol       Date:  2015-10-28       Impact factor: 5.182

Review 7.  IL-13 receptor isoforms: breaking through the complexity.

Authors:  Yasuhiro Tabata; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

Review 8.  Mechanisms of Dupilumab.

Authors:  Hani Harb; Talal A Chatila
Journal:  Clin Exp Allergy       Date:  2019-09-30       Impact factor: 5.018

9.  Plasma-induced signatures reveal an extracellular milieu possessing an immunoregulatory bias in treatment-naive paediatric inflammatory bowel disease.

Authors:  B Gurram; N H Salzman; M L Kaldunski; S Jia; B U K Li; M Stephens; M R Sood; M J Hessner
Journal:  Clin Exp Immunol       Date:  2016-01-29       Impact factor: 4.330

10.  B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.

Authors:  Danielle T Avery; Elissa K Deenick; Cindy S Ma; Santi Suryani; Nicholas Simpson; Gary Y Chew; Tyani D Chan; Umamainthan Palendira; Jacinta Bustamante; Stéphanie Boisson-Dupuis; Sharon Choo; Karl E Bleasel; Jane Peake; Cecile King; Martyn A French; Dan Engelhard; Sami Al-Hajjar; Saleh Al-Muhsen; Klaus Magdorf; Joachim Roesler; Peter D Arkwright; Pravin Hissaria; D Sean Riminton; Melanie Wong; Robert Brink; David A Fulcher; Jean-Laurent Casanova; Matthew C Cook; Stuart G Tangye
Journal:  J Exp Med       Date:  2010-01-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.